Search

Your search keyword '"Sabbour H"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Sabbour H" Remove constraint Author: "Sabbour H"
46 results on '"Sabbour H"'

Search Results

3. Dyslipidaemia and its management in patients with type 2 diabetes across the Middle East and Africa: the PACT-MEA study

4. Cardioprotective pharmacotherapy in patients with type 2 diabetes across the Middle East and Africa: the PACT-MEA study

6. Managing thrombotic risk in patients with diabetes

13. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

14. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

15. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

16. Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry Analysis.

17. Trends and findings of lipoprotein(a) testing and associated cardiovascular disease profiles: a large single-center study from the Middle East-Gulf region.

18. Cardiovascular disease risk scores in patients with optimal vs suboptimal weight loss after bariatric surgery: Translating improvements into clinical practice.

21. Effectiveness and safety of the combination of sodium-glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies.

22. A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty Acids.

23. Flash'O real-world evidence programme - Attitude and practices toward the use of omega-3 FA by physicians from Middle East Countries.

24. Regional expert opinion: Management of heart failure with preserved ejection fraction in the Middle East, North Africa and Turkey.

25. Attacking the Achilles heel of cardiac amyloid nuclear scintigraphy: How to reduce equivocal and false positive studies.

26. Comprehensive description of the prevalence, serological and clinical characteristics, and visceral involvement of systemic sclerosis (scleroderma) in a large cohort from the United Arab Emirates Systemic Sclerosis Registry.

27. A cross-sectional study of the prevalence and clinical management of atherosclerotic cardiovascular diseases in patients with type 2 diabetes across the Middle East and Africa (PACT-MEA): Study design and rationale.

28. Prevalence of Diabetes and Cardiovascular Risk in the Middle East and Africa: Primary Results of the PACT-MEA Study.

29. The First Pulmonary Hypertension Registry in the United Arab Emirates (UAEPH): Clinical Characteristics, Hemodynamic Parameters with Focus on Treatment and Outcomes for Patients with Group 1-PH.

30. Management of Heart Failure in Patients With Diabetes Mellitus in the UAE: A Call to Action.

31. Prevalence of Cardiovascular Risk Factors and 10-Years Risk for Coronary Heart Disease in the United Arab Emirates.

32. Physician Knowledge and Awareness About Cardiac Amyloidosis in the Middle East and Gulf Region.

33. Current gaps in management and timely referral of cardiorenal complications among people with type 2 diabetes mellitus in the Middle East and African countries: Expert recommendations.

34. Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update.

35. From Clinical Clues to Final Diagnosis: The Return of Detective Work to Clinical Medicine in Cardiac Amyloidosis.

36. Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.

37. The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results.

38. Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases.

39. Incidental finding of pulmonary artery aneurysm revealing a congenital heart defect.

40. Practical perspectives on the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation: A view from the Middle East and North Africa.

41. Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East.

42. The Gulf Implantable Cardioverter-defibrillator Registry: Rationale, Methodology, and Implementation.

43. Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel.

45. Cardiac device implant wound closure with 2-octyl cyanoacrylate.

46. Para-Hisian entrainment: a novel pacing maneuver to differentiate orthodromic atrioventricular reentrant tachycardia from atrioventricular nodal reentrant tachycardia.

Catalog

Books, media, physical & digital resources